Q2 2023 EPS Estimates for Amarin Co. plc (NASDAQ:AMRN) Cut by Northland Capmk
Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Northland Capmk cut their Q2 2023 earnings per share (EPS) estimates for Amarin in a report released on Wednesday, July 19th. Northland Capmk analyst C. Byrnes now expects that the biopharmaceutical company will post earnings of ($0.06) per share for the quarter, down from […]